| Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention VB Pai, MC Nahata Drug safety 22, 263-302, 2000 | 973 | 2000 |
| Treatment of listeriosis ME Temple, MC Nahata Annals of Pharmacotherapy 34 (5), 656-661, 2000 | 274 | 2000 |
| Clinical uses of dexmedetomidine in pediatric patients H Phan, MC Nahata Pediatric Drugs 10, 49-69, 2008 | 255 | 2008 |
| Extemporaneous drug formulations MC Nahata, LV Allen Jr Clinical therapeutics 30 (11), 2112-2119, 2008 | 198 | 2008 |
| Lack of pediatric drug formulations MC Nahata Pediatrics 104 (Supplement_3), 607-609, 1999 | 196 | 1999 |
| The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin N Bahal, MC Nahata Annals of Pharmacotherapy 26 (1), 46-55, 1992 | 196 | 1992 |
| Clinical uses of fentanyl, sufentanil, and alfentanil. MA Clotz, MC Nahata Clinical pharmacy 10 (8), 581-593, 1991 | 191 | 1991 |
| Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease SD Candrilli, SH O'Brien, RE Ware, MC Nahata, EE Seiber, R Balkrishnan American journal of hematology 86 (3), 273-277, 2011 | 160 | 2011 |
| Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use MSB Frank, MC Nahata, MD Hilty Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 1 (2 …, 1981 | 146 | 1981 |
| Pediatric drug formulations MC Nahata, VB Pai Harvey Whitney Books, 2011 | 139 | 2011 |
| Efficacy and safety of aerosolized tobramycin in cystic fibrosis VB Pai, MC Nahata Pediatric pulmonology 32 (4), 314-327, 2001 | 139 | 2001 |
| Adverse effects of meperidine, promethazine, and chlorpromazine for sedation in pediatric patients MC Nahata, MA Ootz, EA Krogg Clinical pediatrics 24 (10), 558-560, 1985 | 123 | 1985 |
| Frequency and preventability of adverse drug reactions in paediatric patients ME Temple, RF Robinson, JC Miller, JR Hayes, MC Nahata Drug safety 27, 819-829, 2004 | 119 | 2004 |
| Body mass index in primary and secondary pediatric hypertension RF Robinson, DL Batisky, JR Hayes, MC Nahata, JD Mahan Pediatric Nephrology 19, 1379-1384, 2004 | 116 | 2004 |
| Clinical use of systemic antifungal agents. JM Benson, MC Nahata Clinical pharmacy 7 (6), 424-438, 1988 | 115 | 1988 |
| Drug interactions with azithromycin and the macrolides: an overview M Nahata Journal of antimicrobial chemotherapy 37 (suppl_C), 133-142, 1996 | 114 | 1996 |
| Clinical pharmacokinetics of antibacterial drugs in neonates CM Paap, MC Nahata Clinical pharmacokinetics 19, 280-318, 1990 | 113 | 1990 |
| Management of botulism RF Robinson, MC Nahata Annals of Pharmacotherapy 37 (1), 127-131, 2003 | 106 | 2003 |
| Rimantadine: a clinical perspective SM Wintermeyer, MC Nahata Annals of Pharmacotherapy 29 (3), 299-310, 1995 | 106 | 1995 |
| Nelfinavir mesylate: a protease inhibitor VB Pai, MC Nahata Annals of Pharmacotherapy 33 (3), 325-339, 1999 | 104 | 1999 |
